WIA
ABBV icon

Wealthedge Investment Advisors’s AbbVie ABBV Stock Holding History

Wealthedge Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
944
+7
+0.7% +$1.51K 0.08% 130
2026
Q1 		$204K Buy
937
+10
+1% +$2.22K 0.07% 136
2025
Q4 		$212K Buy
927
+5
+0.5% +$1.14K 0.08% 127
2025
Q3 		$214K Buy
+922
New +$188K 0.08% 123

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealthedge Investment Advisors's ABBV Position: Q2 2026 in Review

Wealthedge Investment Advisors increased its AbbVie (ABBV) stake by 0.75% in Q2 2026, buying an estimated $1.51K and bringing the position to 944 shares worth $238K. The position accounts for 0.08% of the portfolio, ranked #130.

Wealthedge Investment Advisors first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealthedge Investment Advisors held 944 shares of AbbVie worth $238K as of Q2 2026.
  • Wealthedge Investment Advisors bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
  • AbbVie made up 0.08% of Wealthedge Investment Advisors's portfolio in Q2 2026, its #130 holding.
  • Wealthedge Investment Advisors first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealthedge Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.